General Information. Commercial reagents were purified prior to use following the guidelines of Perrin and Armarego.
0.25 mm) column (100 °C isotherm, 1 mL/min); (2S, 3R) isomer t r = 20.6 min, (2R, 3S) isomer t r = 20.8 min, (2R, 3R) isomer t r = 22.0 min, (2S, 3S) isomer t r = 22.9 min.
(2R,3S)-2-Chloro-3-(5-methyl-furan-2-yl)-hexanal (Table 2, entry 2):
Prepared according to the general procedure from 2-methyl furan (22.6 µL, 0.25 mmol), 2- hexenal (87 µL, 0.75 mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien- 1-one isomer t r = 70.8 min, (2S, 3S) isomer t r = 77.8 min, (2R, 3R) isomer t r = 86.4 min. . The diastereomeric ratio was determined by NMR. The enantiomeric ratio was determined by HPLC of the NaBH 4 reduced alcohol using a Chiracel AD and AD guard column (5% i-propanol/ hexanes, 1 mL/min); (2S, 3S) isomer t r = 17.8 min, (2S, 3R) isomer t r = 20.7 min, (2R, 3S) isomer t r = 22.5 min, (2R, 3R) isomer t r = 29.1 min. . The diastereomeric and enantiomeric ratio was determined by GLC using a Bodman Chiraldex Γ−TA (30 m x 0.25 mm) column (120 °C isotherm, 1 mL/min); (2R, 3R) isomer t r = 27.5 min, (2S, 3S) isomer t r = 27.9 min, (2S, 3R) isomer t r = 28.6 min, (2R, 3S) isomer t r = 29.4 min. Table 3, . The diastereomeric and enantiomeric ratio was determined by HPLC of the corresponding alcohol after NaBH 4 reduction using a Chiracel AD and AD guard column (2.5% i-propanol/ hexanes, 1 mL/min); (2S, 3S) isomer t r = 80.6 min, (2S, 3R) isomer t r = 89.0 min, (2R, 3R) isomer t r = 92.4 min, (2R, 3S) isomer t r = 97.6 min. minutes and crotonaldehyde (124 µL, 1.5 mmol) was added in one portion followed by 2- methyl furan (45 µL, 0.5 mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien- 1-one (301 mg, 1 mmol). The resulting solution was stirred at -40 °C for 36 hours and was diluted with ethanol (1 mL), followed by addition of NaBH 4 (75.6 mg, 2 mmol). The
(2R,3S)-3-Chloro-2-(5-methyl-furan-2-yl)-4-oxo-butyric acid methyl ester (

(2R,3S)-2-Chloro-4-methyl-3-(1-methyl-1H-indol-3-yl)-pentanal (
(2R,3S)-2-Chloro-3-(5-methoxy-thiophen-2-yl)-butyraldehyde (
(2R,3S)-2-Chloro-3-((2S)-2-methyl-5-oxo-2,5-dihydro-furan-2-yl)-butyraldehyde (
(2R,3S)-2-chloro-3-((S)-4,5-dihydro-4-methyl-5-oxo-2-phenyloxazol-4-yl)butanal (
